<ѻýҕl>IVF Babies at No Increased Risk of Childhood Cancersѻýҕl> No associations seen with intracytoplasmic sperm injection or frozen embryo transfer, study found Jul 02, 2021
<ѻýҕl>Hold Off on Approving Anal Cancer Drug, Advisors Tell FDAѻýҕl> ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in Jun 24, 2021
<ѻýҕl>No Survival Benefit With All-Oral Regimen for Relapsed/Refractory Myelomaѻýҕl> Prolonging PFS a positive, as advances make OS improvement harder to achieve Jun 18, 2021
<ѻýҕl>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻýҕl> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻýҕl>Fixed-Duration, All-Oral Regimen Slows CLL Progressionѻýҕl> Near-80% reduction in PFS hazard with ibrutinib-venetoclax versus obinutuzumab-chlorambucil Jun 16, 2021
<ѻýҕl>How CAR T-Cell Therapy Measures Up in Follicular Lymphomaѻýҕl> Better response rates and survival with axicabtagene ciloleucel versus external control group Jun 15, 2021
<ѻýҕl>Zanubrutinib Tops Ibrutinib in Relapsed or Refractory CLLѻýҕl> Better overall response rate, less cardiotoxicity, with second-generation BTK inhibitor Jun 14, 2021
<ѻýҕl>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care?ѻýҕl> News, features, and commentary about cancer-related issues Jun 10, 2021
<ѻýҕl>Another CAR-T Impresses in Follicular Lymphomaѻýҕl> Complete responses in 66% of patients with relapsed or refractory disease Jun 08, 2021
<ѻýҕl>Combination Therapy Achieves High Response in Ph+ ALLѻýҕl> Ponatinib-blinatumomab offers promising regimen in frontline and relapse/refractory disease Jun 05, 2021
<ѻýҕl>With Supplements, ADT in Prostate Cancer of Little Threat to Bone Densityѻýҕl> Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
<ѻýҕl>Family Alleges Profit Motives Played Role in 3-Year-Old's Deathѻýҕl> Parents charge care delays for child with hydrocephalus were tied to arrangements for star doctor May 25, 2021
<ѻýҕl>Thiotepa-Based Conditioning Promising for Primary CNS Lymphomaѻýҕl> Commonly used regimens with autologous transplant improved survival May 06, 2021
<ѻýҕl>Vadadustat Matches Standard for CKD-Related Anemia, With Caveatѻýҕl> Jury still out on drug's heart safety, which differed depending on dialysis dependence Apr 28, 2021
<ѻýҕl>Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivorsѻýҕl> Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
<ѻýҕl>Why Clotting Happens When Platelets Are Lowѻýҕl> A hematologist explains the counterintuitive concept of clots with low platelets Apr 23, 2021
<ѻýҕl>Poloxamer 188 Flops for Sickle Cell Disease Painѻýҕl> Study found no difference in duration of vaso-occlusive episodes versus placebo Apr 20, 2021
<ѻýҕl>Targeted Drug Yields Durable Responses in Rare Blood Neoplasmѻýҕl> Most advanced systemic mastocytosis patients responded to KIT D816V inhibitor Apr 13, 2021
<ѻýҕl>Add-On PI3K Inhibitor Wins in Relapsed, Indolent NHLѻýҕl> Adding copanlisib to rituximab also doubled CR rate, with manageable toxicity Apr 10, 2021
<ѻýҕl>From VIPIT to VITT: Thrombosis and COVID Vaccinesѻýҕl> More data support link between adenovirus vector vaccines, blood clotting, and low platelets Apr 09, 2021
<ѻýҕl>Ethics Consult: Stop Treatment for Costly Patient? MD/JD Weighs Inѻýҕl> You voted, now see the results and an expert's discussion Apr 09, 2021
<ѻýҕl>Vaccines and Rare Clotting Disorders: What's the Link?ѻýҕl> Causal relation appears possible, but evidence still indicates it's extremely rare Mar 25, 2021
<ѻýҕl>Marrow Cell Stimulator to Treat Alzheimer's Disease?ѻýҕl> Unusual approach pans out in mid-stage trial Mar 24, 2021
<ѻýҕl>Op-Ed: Blood Cancer Patients Need More COVID Vax Answersѻýҕl> Patients are left wondering, "will I be protected?" Mar 24, 2021
<ѻýҕl>C3 Inhibitor Prevails in Trial of Rare Hemoglobinuriaѻýҕl> Improvement in hemoglobin, transfusion independence with pegcetacoplan for PNH Mar 17, 2021
<ѻýҕl>Holding tPA for All DOAC Users Not the Way to Go, Stroke Docs Sayѻýҕl> Clinical conundrum could be solved by a point-of-care DOAC test Mar 15, 2021
<ѻýҕl>Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemiaѻýҕl> Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
<ѻýҕl>Blincyto Shines for Kids' B-Cell ALLѻýҕl> Overall survival boost seen in new trials Mar 05, 2021
<ѻýҕl>Anti-CD20 Drugs Tied to Severe COVID in Cancer Patientsѻýҕl> Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
<ѻýҕl>Preventive Approach to C-Section Bleeding Pans Out in Trialѻýҕl> Treatment lowered risk of early blood loss and transfusion, but not more severe hemorrhage Jan 29, 2021
<ѻýҕl>Officials Investigate Physician's Death After COVID Vaccinationѻýҕl> Onset of rare blood disorder should not be interpreted as causal, experts say Jan 27, 2021
<ѻýҕl>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻýҕl> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻýҕl>Ethics Consult: Refuse Treatment for Dictator? MD/JD Weighs Inѻýҕl> You voted, now see the results and an expert's discussion Jan 15, 2021
<ѻýҕl>PARP Inhibitors Linked With Blood Cancer Riskѻýҕl> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻýҕl>Non-Hodgkin Lymphoma: Bispecific Antibodies Impress in Refractory Diseaseѻýҕl> Odronextamab, epcoritamab surpass 90% response threshold in early trials Dec 11, 2020
<ѻýҕl>Chemo-Free Combo Boosts PFS in First-Line CLLѻýҕl> PI3K-delta-based regimen also topped chemoimmunotherapy in relapsed setting Dec 08, 2020
<ѻýҕl>Novel Agent Active in Refractory CMLѻýҕl> Asciminib doubles molecular response versus bosutinib after two or more prior lines of therapy Dec 08, 2020
<ѻýҕl>Tranexamic Acid May Hurt Head Trauma Survival for One Key Groupѻýҕl> Cheap antifibrinolytic given en route to hospital safe overall in registry Dec 07, 2020
<ѻýҕl>Fixed-Duration Ibrutinib-Venetoclax Promising in First-Line CLLѻýҕl> DFS at 1 year reaches 95% in patients with undetectable MRD Dec 06, 2020
<ѻýҕl>CRISPR-Based Tx Offers Hope in Tough-to-Treat Blood Disordersѻýҕl> Success with investigational use of gene editing in sickle cell disease, beta-thalassemia Dec 06, 2020